Whalesbook
Granules India Ltd has announced it will hold its earnings conference call on April 29, 2026, to review financial results for the fourth quarter and the full fiscal year ending March 31, 2026. The call is scheduled for 5:00 PM IST.
The discussion will be led by key management figures, including Chairman & Managing Director Dr. Krishna Prasad Chigurupati and Chief Financial Officer Mr. Mukesh Surana. Other senior executives are also expected to participate.
Granules India, headquartered in Hyderabad, is a vertically integrated pharmaceutical company focused on Active Pharmaceutical Ingredients (APIs), Pharmaceutical Intermediates (PFIs), and Finished Dosages (FDs). It holds a significant global position as a producer of high-volume drugs such as Paracetamol and Ibuprofen. The company has expanded its capabilities through acquisitions, including Senn Chemicals AG in February 2025 to enhance its peptide therapeutics business, and entered the U.S. prescription drug market in 2019.
For the three years leading up to April 15, 2026, Granules India reported profit growth of -6.17% and revenue growth of -2.19%.
The company has recently faced scrutiny from the U.S. Food and Drug Administration (FDA) concerning record-keeping and contamination control practices at some manufacturing sites. Granules India is implementing corrective actions, including digitization and automation, to improve oversight and address these issues.
Granules India operates within a competitive pharmaceutical sector, alongside major players like Sun Pharmaceutical Industries, Divi's Laboratories, Cipla, and Dr. Reddy's Laboratories. While Granules India benefits from its integrated model, some competitors have seen stronger recent stock performance.
Investors will be looking for clarity on the company's financial outcomes for Q4 and FY26 during the call. Management commentary will offer insights into market trends, strategic initiatives, and the progress of corrective actions related to FDA observations. The call is a key opportunity for shareholders to gauge the company's future business strategies and market positioning.